Control of A1C, blood pressure and cholesterol among patients with diabetes has improved markedly, but more room for improvement remains, according to a new study.

The Food and Drug Administration has approved a generic diabetes drug made by Macleods Pharma, according to agency records.

Sam's Club will offer free heart health screenings at 563 of its stores on Saturday, the club retailer said.

A university research project to look at the potential effects on patient health of incorporating medication management strategies into existing care teams has won a grant from the National Association of Chain Drug Stores' philanthropic arm.

A new study conducted by researchers at the University of Minnesota and nearby healthcare institutions shows that patients with diabetes experience better outcomes when they undergo face-to-face medication therapy management sessions with pharmacists.

Drug Store News has reported enough about the benefits of MTM to fill a book, but a scientific study showing a demonstrable benefit to it only makes the case stronger. It speaks to the growing role of the pharmacist as a key member of the patient's healthcare team, every bit as important as nurses and doctors, and also points to a role of growing importance to pharmacy retailers themselves as they seek to distinguish themselves in the marketplace.

The Food and Drug Administration has approved three new drugs for Type 2 diabetes made by Takeda, the agency said.

A panel of Food and Drug Administration experts has recommended approval for an experimental Type 2 diabetes drug made by Johnson & Johnson, the drug maker said.

Novo Nordisk has appointed Curtis Oltmans as its corporate VP and general counsel for legal and quality affairs, the company said Friday.

Diabetes patients at Kroger pharmacies who have private insurance can pay $4 for blood-glucose test strips, the supermarket operator said.

Drug maker Novo Nordisk is creating what it calls the world's first all-diabetes professional cycling team, the company said.

Personal care company Naterra has announced the national launch of Phase+, a skin care line designed to address the cosmetic effects that diabetes has on the skin.